SE0300119D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0300119D0 SE0300119D0 SE0300119A SE0300119A SE0300119D0 SE 0300119 D0 SE0300119 D0 SE 0300119D0 SE 0300119 A SE0300119 A SE 0300119A SE 0300119 A SE0300119 A SE 0300119A SE 0300119 D0 SE0300119 D0 SE 0300119D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- novel compounds
- compounds
- formula
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300119A SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Novel compounds |
AU2004206012A AU2004206012B2 (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
JP2006500750A JP4519121B2 (ja) | 2003-01-17 | 2004-01-15 | 自己免疫疾患の調節におけるチエノピリミジンジオンとその使用 |
CA2512441A CA2512441C (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
PCT/SE2004/000052 WO2004065394A1 (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
BRPI0406801A BRPI0406801B8 (pt) | 2003-01-17 | 2004-01-15 | derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes |
CNB2004800071073A CN100334093C (zh) | 2003-01-17 | 2004-01-15 | 噻吩并嘧啶二酮及其在调节自身免疫疾病中的用途 |
PL378222A PL214682B1 (pl) | 2003-01-17 | 2004-01-15 | Tienopirymidynodiony, sposób ich wytwarzania oraz zawierajacy je srodek farmaceutyczny |
NZ541217A NZ541217A (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
RU2005121494/04A RU2331647C2 (ru) | 2003-01-17 | 2004-01-15 | Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания |
US10/542,197 US7384951B2 (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
DE602004001857T DE602004001857T2 (de) | 2003-01-17 | 2004-01-15 | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen |
AT04702477T ATE335748T1 (de) | 2003-01-17 | 2004-01-15 | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen |
ES04702477T ES2270337T3 (es) | 2003-01-17 | 2004-01-15 | Tienopirimidindionas y su uso en la modulacion de la enfermedad autoinmunitaria. |
KR1020117022785A KR20110125256A (ko) | 2003-01-17 | 2004-01-15 | 티에노피리미딘디온 및 그들의 자가면역 질환 조절 용도 |
UAA200506377A UA81788C2 (uk) | 2003-01-17 | 2004-01-15 | Тієнопіримідиндіони і їх використання у модуляції аутоімунних хвороб |
MXPA05007496A MXPA05007496A (es) | 2003-01-17 | 2004-01-15 | Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes. |
EP04702477A EP1587812B1 (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
KR1020057013126A KR101107486B1 (ko) | 2003-01-17 | 2004-01-15 | 티에노피리미딘디온 및 그들의 자가면역 질환 조절 용도 |
IL169370A IL169370A (en) | 2003-01-17 | 2005-06-23 | Thianopyrimidinedione and their use in the modulation of disease and immune failure |
ZA2005/05364A ZA200505364B (en) | 2003-01-17 | 2005-07-01 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
EGNA2005000380 EG25613A (en) | 2003-01-17 | 2005-07-12 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
IS7965A IS2376B (is) | 2003-01-17 | 2005-07-29 | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi |
NO20053826A NO333702B1 (no) | 2003-01-17 | 2005-08-15 | Tienopyrimidindioner, fremgangsmater for deres fremstilling, farmasoytiske preparater som inneholder dem og deres anvendelse i terapi. |
HK06102161A HK1081959A1 (en) | 2003-01-17 | 2006-02-17 | Thienopyriminediones and their use in the modulation of autoimmune disease |
US12/115,171 US20080214579A1 (en) | 2003-01-17 | 2008-05-05 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300119A SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0300119D0 true SE0300119D0 (sv) | 2003-01-17 |
Family
ID=20290154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0300119A SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Novel compounds |
Country Status (24)
Country | Link |
---|---|
US (2) | US7384951B2 (sv) |
EP (1) | EP1587812B1 (sv) |
JP (1) | JP4519121B2 (sv) |
KR (2) | KR101107486B1 (sv) |
CN (1) | CN100334093C (sv) |
AT (1) | ATE335748T1 (sv) |
AU (1) | AU2004206012B2 (sv) |
BR (1) | BRPI0406801B8 (sv) |
CA (1) | CA2512441C (sv) |
DE (1) | DE602004001857T2 (sv) |
EG (1) | EG25613A (sv) |
ES (1) | ES2270337T3 (sv) |
HK (1) | HK1081959A1 (sv) |
IL (1) | IL169370A (sv) |
IS (1) | IS2376B (sv) |
MX (1) | MXPA05007496A (sv) |
NO (1) | NO333702B1 (sv) |
NZ (1) | NZ541217A (sv) |
PL (1) | PL214682B1 (sv) |
RU (1) | RU2331647C2 (sv) |
SE (1) | SE0300119D0 (sv) |
UA (1) | UA81788C2 (sv) |
WO (1) | WO2004065394A1 (sv) |
ZA (1) | ZA200505364B (sv) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
KR20050092761A (ko) * | 2003-01-17 | 2005-09-22 | 아스트라제네카 아베 | 티에노피리다지논 및 그들의 자가면역 질환 조절 용도 |
SE0300120D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
CA2608733A1 (en) | 2005-05-17 | 2007-02-01 | Plexxikon, Inc. | Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors |
SI2395004T1 (sl) | 2005-06-22 | 2016-05-31 | Plexxikon Inc. | Derivati piro (2,3-b) piridina kot inhibitorji proteinske kinaze |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
WO2008080015A2 (en) | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
PE20081581A1 (es) | 2006-12-21 | 2008-11-12 | Plexxikon Inc | COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA |
WO2008079909A1 (en) | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Pyrrolo [2,3-b] pyridines as kinase modulators |
GB0713479D0 (en) * | 2007-07-11 | 2007-08-22 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン,インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
WO2010089580A1 (en) | 2009-02-06 | 2010-08-12 | Astrazeneca Ab | Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4 |
AU2010227225A1 (en) * | 2009-03-23 | 2011-09-15 | Glenmark Pharmaceuticals, S.A. | Furopyrimidinedione derivatives as TRPA1 modulators |
SG174403A1 (en) * | 2009-03-23 | 2011-10-28 | Glenmark Pharmaceuticals Sa | Isothiazolo-pyrimidinedione derivatives as trpa1 modulators |
PE20120876A1 (es) | 2009-04-03 | 2012-08-05 | Hoffmann La Roche | Composiciones del acido propano-1-sulfonico{3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil}-amida |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
PE20121327A1 (es) | 2009-11-06 | 2012-10-18 | Plexxikon Inc | Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello |
PL2672967T3 (pl) | 2011-02-07 | 2019-04-30 | Plexxikon Inc | Związki i sposoby modulacji kinaz i wskazania ku temu |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
US9296728B2 (en) | 2012-01-20 | 2016-03-29 | Regents Of The University Of Minnesota | Therapeutic compounds |
WO2013112881A1 (en) | 2012-01-27 | 2013-08-01 | Thomas Jefferson University | Mct protein inhibitor-related prognostic and therapeutic methods |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
EP2986290A4 (en) | 2013-04-19 | 2017-01-04 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
MY184561A (en) * | 2013-10-21 | 2021-04-03 | Genosco | Substituted pyrimidine compounds and their use as syk inhibitors |
US10329303B2 (en) | 2015-01-22 | 2019-06-25 | The Scripps Research Institute | Heterocyclic inhibitors of monocarboxylate transporter |
UY36586A (es) * | 2015-03-26 | 2016-10-31 | Bayer Pharma AG | Heterociclilmetiltienouracilos y uso de los mismos |
KR101730536B1 (ko) * | 2016-03-17 | 2017-05-02 | 주식회사 골프존 | 스크린 골프 시스템에서 구현되는 컨텐츠 전송 서비스 방법, 컨텐츠 전송 서비스를 위한 모바일 단말기의 제어방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록매체 |
KR101712838B1 (ko) * | 2016-03-17 | 2017-03-07 | 주식회사 골프존 | 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체 |
KR101712836B1 (ko) * | 2016-03-17 | 2017-03-22 | 주식회사 골프존 | 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체 |
TWI823932B (zh) | 2018-05-11 | 2023-12-01 | 中國大陸商迪哲(江蘇)醫藥有限公司 | 三唑并嘧啶化合物及其在治療癌症中之用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US738495A (en) * | 1902-12-26 | 1903-09-08 | William E Sherwood | Thill-coupling. |
WO1999029695A1 (en) | 1997-12-05 | 1999-06-17 | Astrazeneca Uk Limited | Novel compounds |
SE9702001D0 (sv) | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
US6469014B1 (en) * | 1997-05-28 | 2002-10-22 | Astrazeneca Ab | Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
DK1107973T3 (da) * | 1998-08-28 | 2004-02-23 | Astrazeneca Ab | Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi |
AU2001252825A1 (en) * | 2000-05-04 | 2001-11-12 | Astrazeneca Ab | Thieno(2,3-d)pyrimidinediones and their use as pharmaceuticals |
GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
GB0118479D0 (en) | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
SE0300120D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
KR20050092761A (ko) * | 2003-01-17 | 2005-09-22 | 아스트라제네카 아베 | 티에노피리다지논 및 그들의 자가면역 질환 조절 용도 |
-
2003
- 2003-01-17 SE SE0300119A patent/SE0300119D0/sv unknown
-
2004
- 2004-01-15 KR KR1020057013126A patent/KR101107486B1/ko active IP Right Grant
- 2004-01-15 AT AT04702477T patent/ATE335748T1/de not_active IP Right Cessation
- 2004-01-15 CA CA2512441A patent/CA2512441C/en not_active Expired - Lifetime
- 2004-01-15 AU AU2004206012A patent/AU2004206012B2/en not_active Ceased
- 2004-01-15 EP EP04702477A patent/EP1587812B1/en not_active Expired - Lifetime
- 2004-01-15 UA UAA200506377A patent/UA81788C2/uk unknown
- 2004-01-15 MX MXPA05007496A patent/MXPA05007496A/es active IP Right Grant
- 2004-01-15 KR KR1020117022785A patent/KR20110125256A/ko not_active Application Discontinuation
- 2004-01-15 PL PL378222A patent/PL214682B1/pl unknown
- 2004-01-15 WO PCT/SE2004/000052 patent/WO2004065394A1/en active IP Right Grant
- 2004-01-15 JP JP2006500750A patent/JP4519121B2/ja not_active Expired - Fee Related
- 2004-01-15 CN CNB2004800071073A patent/CN100334093C/zh not_active Expired - Fee Related
- 2004-01-15 ES ES04702477T patent/ES2270337T3/es not_active Expired - Lifetime
- 2004-01-15 RU RU2005121494/04A patent/RU2331647C2/ru not_active IP Right Cessation
- 2004-01-15 NZ NZ541217A patent/NZ541217A/en not_active IP Right Cessation
- 2004-01-15 BR BRPI0406801A patent/BRPI0406801B8/pt not_active IP Right Cessation
- 2004-01-15 DE DE602004001857T patent/DE602004001857T2/de not_active Expired - Lifetime
- 2004-01-15 US US10/542,197 patent/US7384951B2/en not_active Expired - Lifetime
-
2005
- 2005-06-23 IL IL169370A patent/IL169370A/en active IP Right Grant
- 2005-07-01 ZA ZA2005/05364A patent/ZA200505364B/en unknown
- 2005-07-12 EG EGNA2005000380 patent/EG25613A/xx active
- 2005-07-29 IS IS7965A patent/IS2376B/is unknown
- 2005-08-15 NO NO20053826A patent/NO333702B1/no not_active IP Right Cessation
-
2006
- 2006-02-17 HK HK06102161A patent/HK1081959A1/xx not_active IP Right Cessation
-
2008
- 2008-05-05 US US12/115,171 patent/US20080214579A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0300119D0 (sv) | Novel compounds | |
HK1048990A1 (en) | Novel compounds. | |
IS6658A (is) | Ný efnasambönd | |
SE0301700D0 (sv) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
SE0200920D0 (sv) | Novel compounds | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
SE0300480D0 (sv) | Novel compounds | |
TW200833670A (en) | Novel compounds 569 | |
TW200604197A (en) | New compounds | |
SE0402925D0 (sv) | Novel Compounds | |
SE0101038D0 (sv) | Novel compounds | |
GB0120461D0 (en) | Novel compounds | |
SE0303280D0 (sv) | Novel compounds | |
SE0401763D0 (sv) | Compounds | |
IL172538A0 (en) | Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
SE0302755D0 (sv) | Novel compounds | |
SE0202693D0 (sv) | Compounds | |
SE0403118D0 (sv) | New compounds 2 | |
MXPA05007495A (es) | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. | |
SE0403117D0 (sv) | New compounds 1 | |
SE0300117D0 (sv) | Novel Compounds | |
SE0004480D0 (sv) | Novel compounds |